Retrieve available abstracts of 17 articles: HTML format
Single Articles
May 2025
SLEEM R, Salah A, Alziz AA, Daif AA, et al Inhibition of hepatitis C virus replication in HepG2 cells via modulation of the
Raf-1 and interferon-alpha signaling pathways by thymoquinone.
Arch Virol. 2025;170:120. PubMedAbstract available
DA SILVA H, Juniastuti, Amin M, Soares J, et al Genotypes, subtypes, and genetic variability of hepatitis B virus from blood
donors in Timor-Leste.
Arch Virol. 2025;170:119. PubMedAbstract available
March 2025
SUPEKAR R, Sarkar J, Chakrabarti P, Biswas S, et al Diagnostic challenges due to hepatitis B virus surface antigen mutations outside
the major hydrophilic region.
Arch Virol. 2025;170:71. PubMedAbstract available
December 2024
BIRLEM GE, Sita A, Gularte JS, de Souza da Silva D, et al Detection of a novel hepacivirus in wild cavies (Cavia aperea aperea).
Arch Virol. 2024;170:19. PubMedAbstract available
November 2024
TRIPATHY AS, Wagh P, Shahapure G, Walimbe AM, et al Association of IL1RN VNTR and NKG2A polymorphisms with hepatitis E infection, a
case study from western India.
Arch Virol. 2024;169:250. PubMedAbstract available
JIAO Q, Zhu S, Liao B, Liu H, et al An NLR family member X1 mutation (p.Arg707Cys) suppresses hepatitis B virus
infection in hepatocytes and favors the interaction of retinoic acid-inducible
gene 1 with mitochondrial antiviral signaling protein.
Arch Virol. 2024;169:238. PubMedAbstract available
ALMAS I, Tariq S, Amin I, Shahid M, et al Molecular epidemiology and genetic characterization of hepatitis B virus in two
major provinces of Pakistan.
Arch Virol. 2024;169:239. PubMedAbstract available
October 2024
KHAN S, Aggarwal S, Bhatia P, Yadav AK, et al Glucose and glutamine drive hepatitis E virus replication.
Arch Virol. 2024;169:233. PubMedAbstract available
September 2024
NJIFON AM, Modiyinji AF, Monamele CG, Mbouyap PR, et al A decade-long retrospective study of hepatitis C virus genetic diversity in
Cameroon, 2013-2023: presence of a high proportion of unsubtypable and putative
recombinant HCV strains.
Arch Virol. 2024;169:197. PubMedAbstract available
June 2024
SHALABY S, Awadin W, Karam R, Salem S, et al Pathological and phylogenetic characterization of a rare fowl adenovirus
(FAdV-8b) associated with inclusion body hepatitis in naturally infected
Meleagris gallopavo.
Arch Virol. 2024;169:146. PubMedAbstract available
April 2024
DAS S, Behera P, Shewale DJ, Bodele J, et al Development of an effective single-chain variable fragment recognizing a novel
epitope in the hepatitis C virus E2 protein that restricts virus entry into
hepatocytes.
Arch Virol. 2024;169:112. PubMedAbstract available
SEDOHARA A, Takahashi K, Arai K, Arizono K, et al Characterization of mutations in hepatitis B virus DNA isolated from Japanese
HBsAg-positive blood donors in 2021 and 2022.
Arch Virol. 2024;169:103. PubMedAbstract available
WANG S, Xie Y, Liu F, Wang J, et al miR-3188 inhibits hepatitis B virus transcription by targeting Bcl-2.
Arch Virol. 2024;169:88. PubMedAbstract available
February 2024
SAID EM, Abdulaziz BA, Kassas ME, El Attar IH, et al Retraction Note: High success rates for the use of
sofosbuvir/ombitasvir/paritaprevir/ritonavir + ribavirin and
sofosbuvir/simeprevir/daclatasvir + ribavirin in retreatment of chronic hepatitis
C infection after unsuccessful sofosbuvir/daclatasvir the
Arch Virol. 2024;169:45. PubMed
January 2024
MA X, Li Y, Zhu H, Lu K, et al ENPP1 inhibits the transcription activity of the hepatitis B virus pregenomic
promoter by upregulating the acetylation of LMNB1.
Arch Virol. 2024;169:36. PubMedAbstract available
GUPTA S, Parveen S Potential role of microRNAs in personalized medicine against hepatitis: a
futuristic approach.
Arch Virol. 2024;169:33. PubMedAbstract available
October 2023
GAO H, Fan H, Xie H miR-HCC2 suppresses hepatitis B virus replication by inhibiting the activity of
the enhancer I/X promoter.
Arch Virol. 2023;168:282. PubMedAbstract available